Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 902219 Boston, MA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,530,312
+$1,401,951 QoQ
Shares Held
40,202
+149.9% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. TARS ranks #105 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,530,312 40,202
2026-03-31 $1,128,361 16,085
2025-12-31 $1,373,781 16,778
2025-09-30 $1,031,049 17,349
2025-06-30 $5,008,492 123,636
2025-03-31 $5,964,568 116,110
2024-12-31 $7,574,336 136,795
2024-09-30 $4,780,460 145,347
2024-06-30 $3,460,772 127,328
2024-03-31 $4,050,188 111,422